Amgen’s muscle disorder drug has achieved a major late-stage study goal
Amgen said Tuesday that its drug helped improve daily activities, including chewing and swallowing, in patients suffering from a rare disease that causes muscle weakness, meeting the primary goal of a late-stage study.
POPULAR POSTS
IEA warns ‘electricity era’ will come after fossil fuels peak
October 17, 2024
Easter Island fights global plastic waste vortex
October 17, 2024
Egypt opens more galleries at its antiquities museum
October 17, 2024
LIVE STREAM